Legend Biotech Corporation
LEGN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$158 | -$520 | -$446 | -$407 |
| Dep. & Amort. | $23 | $20 | $18 | $14 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $69 | $48 | $34 | $20 |
| Change in WC | $20 | -$71 | $181 | $162 |
| Other Non-Cash | -$98 | $130 | $11 | $13 |
| Operating Cash Flow | -$144 | -$393 | -$201 | -$198 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$14 | -$20 | -$21 | -$42 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$2,712 | -$4,863 | -$655 | -$378 |
| Inv. Sales/Matur. | $1,930 | $5,077 | $615 | $230 |
| Other Inv. Act. | -$54 | -$101 | -$16 | -$5 |
| Investing Cash Flow | -$851 | $93 | -$77 | -$195 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$4 | -$4 | -$3 | -$1 |
| Stock Issued | $0 | $584 | $378 | $623 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $10 | $212 | $3 | $5 |
| Financing Cash Flow | $6 | $791 | $378 | $627 |
| Forex Effect | -$2 | $1 | -$3 | $0 |
| Net Chg. in Cash | -$991 | $492 | $97 | $233 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $1,278 | $786 | $689 | $456 |
| End Cash | $287 | $1,278 | $786 | $689 |
| Free Cash Flow | -$158 | -$416 | -$224 | -$244 |